AU3170697A - Transdermal drug delivery device for the delivery of tropisetron or granisetron - Google Patents

Transdermal drug delivery device for the delivery of tropisetron or granisetron

Info

Publication number
AU3170697A
AU3170697A AU31706/97A AU3170697A AU3170697A AU 3170697 A AU3170697 A AU 3170697A AU 31706/97 A AU31706/97 A AU 31706/97A AU 3170697 A AU3170697 A AU 3170697A AU 3170697 A AU3170697 A AU 3170697A
Authority
AU
Australia
Prior art keywords
tropisetron
granisetron
transdermal drug
delivery
delivery device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31706/97A
Inventor
Jochem Effing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Publication of AU3170697A publication Critical patent/AU3170697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
AU31706/97A 1997-05-30 1997-05-30 Transdermal drug delivery device for the delivery of tropisetron or granisetron Abandoned AU3170697A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1997/002842 WO1998053815A1 (en) 1997-05-30 1997-05-30 Transdermal drug delivery device for the delivery of tropisetron or granisetron

Publications (1)

Publication Number Publication Date
AU3170697A true AU3170697A (en) 1998-12-30

Family

ID=8166640

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31706/97A Abandoned AU3170697A (en) 1997-05-30 1997-05-30 Transdermal drug delivery device for the delivery of tropisetron or granisetron

Country Status (2)

Country Link
AU (1) AU3170697A (en)
WO (1) WO1998053815A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2261178T3 (en) * 1999-02-09 2006-11-16 Samyang Corporation A TRANSDERMAL COMPOSITION OF AN ANTI-VOMITING AGENT AND A PREPARATION OF THE SAME.
ATE434437T1 (en) * 1999-02-18 2009-07-15 Novasearch Ag USE OF ANTAGONISTS OF 5-HT3 RECEPTORS FOR THE TREATMENT OF MUSCULOESKELETAL DISEASES
US20050042194A1 (en) 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
GB0119012D0 (en) * 2001-08-03 2001-09-26 Strakan Group Plc Transdermal delivery of drugs
AU2003237657A1 (en) * 2002-05-24 2003-12-12 Epidauros Biotechnologie Ag Means and methods for improved treatment using "setrones"
IL152575A (en) 2002-10-31 2008-12-29 Transpharma Medical Ltd Transdermal delivery system for water insoluble drugs
IL152573A (en) 2002-10-31 2009-11-18 Transpharma Medical Ltd Transdermal delivery system for anti-emetic medication
GB0302662D0 (en) * 2003-02-05 2003-03-12 Strakan Ltd Transdermal granisetron
KR20070072867A (en) * 2004-09-01 2007-07-06 넥스메드 홀딩스 인코포레이티드 Transdermal antiemesis delivery system, method and composition therefor
CN101180018B (en) * 2005-05-18 2014-02-26 亚贝丽制药公司 Transdermal method and patch for nausea
US20060263421A1 (en) 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
KR100929560B1 (en) * 2008-01-09 2009-12-03 에코 퍼시픽 엘티디 Percutaneous Absorbent in Matrix Form Containing Granitone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2154892A (en) * 1991-05-07 1992-12-21 Dynagen, Inc. A controlled, sustained release delivery system for treating drug dependency
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
JPH0834731A (en) * 1994-07-26 1996-02-06 T T S Gijutsu Kenkyusho:Kk Granisetron-containing percutaneous preparation
JP4102901B2 (en) * 1994-09-14 2008-06-18 スリーエム カンパニー Matrix for transdermal drug introduction

Also Published As

Publication number Publication date
WO1998053815A1 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
AU5106890A (en) Device for the transdermal delivery of nicotine
AU6853596A (en) Transdermal drug delivery device having enhanced adhesion
AU2109195A (en) Two-component device for the administration of drugs
AU3275089A (en) Transdermal drug delivery device
AU1302499A (en) Buffered drug formulations for transdermal electrotransport delivery
AU7286996A (en) Thermopile powered transdermal drug delivery device
IL124629A0 (en) Transdermal device for the delivery of flurbiprofen
AU3399197A (en) Device for enhancing transdermal agent delivery or sampling
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
AU1585601A (en) Transdermal administration of huperzine
AU5397996A (en) Iontophoretic transdermal system for the administration of at least two substances
HUP0001748A3 (en) Transdermal device for the delivery of testosterone
AU6410494A (en) Device for the transdermal administration of alprazolam
AU3825595A (en) Improved iontophoretic drug delivery device
WO1997037640A3 (en) Uniform drug delivery therapy
AU3170697A (en) Transdermal drug delivery device for the delivery of tropisetron or granisetron
AU7662400A (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
AU4656596A (en) Transdermal formulation
AU2345695A (en) Pharmaceutical composition for transdermal delivery
AU4774296A (en) Transdermal formulation
EP0683668A4 (en) Compositions and methods for transdermal drug delivery.
AU3837999A (en) Drug delivery device
AU4914396A (en) Transdermal formulation
AU6617798A (en) Extensible transdermal therapeutic system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase